Tectonic Therapeutic Cash Flow Statement (2017-2026) | TECX

Cash Flow Statement Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-37.34M-32.62M-28.30M-31.12M-29.30M-24.02M-25.54M-25.97M-10.64M-11.09M-9.28M-13.23M-12.67M-17.72M-9.87M-16.00M-19.98M-19.04M-19.23M-53.80M
Depreciation and Depletion (Quarter)
0.20M0.26M0.26M0.28M
Share-based Compensation (Quarter)
4.69M5.17M-14.49M0.00M3.23M2.66M0.00M2.53M1.53M0.28M0.29M0.32M0.40M1.65M-1.97M2.10M24.00M2.82M2.99M3.73M
Gains from Investment Securities (Quarter)
Asset Writedowns and Impairment (Quarter)
0.04M
Cash from Operations (Quarter)
-19.96M-24.82M-25.90M-28.01M-29.11M-16.41M-23.67M-20.28M-0.26M-8.48M-11.66M-9.27M-13.38M-19.60M-16.82M-13.08M-14.72M-17.82M-14.46M-18.41M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter)
0.07M0.08M0.10M0.07M0.08M0.99M0.29M0.30M0.31M-0.47M0.51M0.52M0.54M0.55M0.50M
Depreciation & Amortization (CF) (Quarter)
0.30M0.37M0.44M0.40M0.35M0.34M0.34M0.33M0.29M0.37M0.37M0.38M0.34M0.42M0.51M0.36M0.34M0.34M0.33M0.30M
Change in Working Capital
Change in Account Payables (Quarter)
-0.63M0.94M0.52M0.55M-4.01M1.79M-1.43M0.21M1.50M2.31M-4.18M1.51M-1.58M0.09M-1.44M1.58M0.14M-1.26M-0.34M1.38M
Change in Accured Expenses (Quarter)
4.83M4.56M-3.42M-2.88M-0.26M1.83M-2.60M-0.65M2.30M-1.88M1.85M1.38M-1.23M-2.60M-3.19M-3.42M2.26M0.03M0.57M1.63M
Other Working Capital Changes (Quarter)
0.28M-0.89M-0.32M-0.33M-0.34M0.43M-0.55M-0.57M-0.58M-0.59M-0.15M
Investing Activities
Capital Expenditures (Quarter)
0.06M1.44M0.85M0.03M0.04M-0.07M0.27M0.01M0.21M-0.21M-0.00M-0.02M0.02M0.15M0.00M0.03M0.18M0.02M
Sales of Property, Plant and Equipment (Quarter)
0.01M
Cash from Investing Activities (Quarter)
-1.23M-0.27M-0.85M-0.03M-0.15M-0.09M-0.01M-0.21M-0.01M-0.05M-0.00M0.00M-0.15M-0.00M-0.03M0.06M-0.17M-0.02M
Financing Activities
Other financing activities (Quarter)
0.02M0.05M0.06M0.04M0.12M0.60M1.62M177.27M-4.17M0.10M
Change in Capital Stock
Shares Issued (Quarter)
8.41M8.00M7.42M9.47M8.91M8.08M9.42M3.86M4.18M3.61M1.00M4.81M1.80M0.09M0.03M1.95M2.18M
Net Equity Issued and Repurchased (Quarter)
-0.15M0.41M0.14M0.00M0.06M0.00M0.01M0.07M0.00M
Misc.
Cash from Financing Activities (Quarter)
14.61M0.02M14.95M0.14M0.00M0.06M0.06M0.06M-0.32M-0.11M34.13M-0.67M179.74M-6.29M-1.07M178.12M-4.17M-0.46M-0.14M0.85M
Exchange Rate Effect (Quarter)
0.02M-0.08M0.02M0.01M0.04M-0.01M-0.03M-0.02M-0.04M0.09M
Change in Cash (Quarter)
-6.59M-25.07M-11.80M-27.90M-29.25M-16.44M-23.61M-20.24M-0.80M-8.60M22.44M-10.02M166.38M-26.03M-17.86M165.01M-18.86M-18.46M-14.64M-17.49M
Free Cash Flow (Quarter)
-20.02M-26.26M-26.75M-28.05M-29.15M-16.34M-23.94M-20.29M-0.47M-8.27M-11.65M-9.25M-13.41M-19.76M-16.82M-13.11M-14.72M-18.00M-14.46M-18.44M
Net Cash Flow (Quarter)
-6.59M-25.07M-11.80M-27.90M-29.25M-16.44M-23.61M-20.24M-0.80M-8.60M22.42M-9.95M166.36M-26.04M-17.89M165.01M-18.83M-18.44M-14.60M-17.59M